These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9293161)

  • 41. Herpetic eye disease: immunopathogenesis and therapeutic measures.
    Deshpande S; Banerjee K; Biswas PS; Rouse BT
    Expert Rev Mol Med; 2004 Mar; 6(8):1-14. PubMed ID: 15061872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis.
    Thomas J; Gangappa S; Kanangat S; Rouse BT
    J Immunol; 1997 Feb; 158(3):1383-91. PubMed ID: 9013983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions.
    Rajasagi NK; Suryawanshi A; Sehrawat S; Reddy PB; Mulik S; Hirashima M; Rouse BT
    J Immunol; 2012 May; 188(9):4631-43. PubMed ID: 22467659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of viral and host genes in corneal infection with herpes simplex virus type 1.
    Brandt CR
    Exp Eye Res; 2005 May; 80(5):607-21. PubMed ID: 15862167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.
    Heiligenhaus A; Bauer D; Meller D; Steuhl KP; Tseng SC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1969-74. PubMed ID: 11481259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis.
    Lepisto AJ; Xu M; Yagita H; Weinberg AD; Hendricks RL
    J Leukoc Biol; 2007 Mar; 81(3):766-74. PubMed ID: 17185358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection.
    Gangappa S; Deshpande SP; Rouse BT
    Eur J Immunol; 1999 Nov; 29(11):3674-82. PubMed ID: 10556823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of cytokines in experimental herpes simplex keratitis.
    Arrunategui-Correa V; Baltatzis S; Foster CS
    Acta Virol; 1999 Oct; 43(5):325-9. PubMed ID: 10757234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of Igh-1 disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis.
    Akova YA; Dutt J; Rodriguez A; Jabbur N; Foster CS
    Curr Eye Res; 1993 Dec; 12(12):1093-101. PubMed ID: 7907969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
    Banerjee K; Biswas PS; Rouse BT
    J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
    Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunopathogenesis of herpetic ocular disease.
    Thomas J; Rouse BT
    Immunol Res; 1997; 16(4):375-86. PubMed ID: 9439761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection.
    Buela KA; Hendricks RL
    J Immunol; 2015 Jan; 194(1):379-87. PubMed ID: 25422507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of T cell receptor V beta gene expression in B cell deficient mice after experimental herpes simplex virus keratitis.
    Arrunategui-Correa V; Dutt JE; Foster CS
    Acta Virol; 1997 Jun; 41(3):145-52. PubMed ID: 9385402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide.
    Avery AC; Zhao ZS; Rodriguez A; Bikoff EK; Soheilian M; Foster CS; Cantor H
    Nature; 1995 Aug; 376(6539):431-4. PubMed ID: 7630419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.
    Gaddipati S; Estrada K; Rao P; Jerome AD; Suvas S
    J Immunol; 2015 Jan; 194(1):273-82. PubMed ID: 25411200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bystander activation involving T lymphocytes in herpetic stromal keratitis.
    Deshpande S; Zheng M; Lee S; Banerjee K; Gangappa S; Kumaraguru U; Rouse BT
    J Immunol; 2001 Sep; 167(5):2902-10. PubMed ID: 11509638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.
    Zhao ZS; Granucci F; Yeh L; Schaffer PA; Cantor H
    Science; 1998 Feb; 279(5355):1344-7. PubMed ID: 9478893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MHC II-restricted, CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice.
    Doymaz MZ; Foster CM; Destephano D; Rouse BT
    Clin Immunol Immunopathol; 1991 Dec; 61(3):398-409. PubMed ID: 1934628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.